Beyond Air Awarded National Group Purchasing Agreement For Inhaled Nitric Oxide Therapy With U.S. Group Purchasing Organization

Beyond Air, Inc. (NASDAQ: XAIR) has secured a national group purchasing agreement for its inhaled nitric oxide therapy with a prominent U.S. group purchasing organization, effective April 1, 2026. This agreement will enable member hospitals and health systems to utilize the LungFit® PH system, enhancing access to Beyond Air's products. The deal strengthens Beyond Air's existing partnerships with major U.S. GPOs, including Vizient and Premier, Inc.